Boston Scientific touts early results of real-world Watchman FLX study

Boston Scientific shared preliminary results on Monday from a real-world analysis following 16,000 patients who were implanted with its Watchman FLX device. The implant, which seals off the left atrial appendage, is intended to reduce stroke risk in patients with non-valvular atrial fibrillation.